H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-OH structure
|
Common Name | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-OH | ||
|---|---|---|---|---|
| CAS Number | 64315-16-8 | Molecular Weight | 1759.015 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C85H123N21O20 | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
| Name | Angiotensinogen |
|---|---|
| Synonym | More Synonyms |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Molecular Formula | C85H123N21O20 |
| Molecular Weight | 1759.015 |
| Exact Mass | 1757.925293 |
| LogP | 4.09 |
| Index of Refraction | 1.658 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
|
Blockade of CCR2 reduces macrophage influx and development of chronic renal damage in murine renovascular hypertension.
Am. J. Physiol. Renal Physiol. 310 , F372-84, (2016) Renovascular hypertension (RVH) is a common cause of both cardiovascular and renal morbidity and mortality. In renal artery stenosis (RAS), atrophy in the stenotic kidney is associated with an influx ... |
| Serine, α-aspartylarginylvalyltyrosylisoleucylhistidylprolylphenylalanylhistidylleucylleucylvalyltyrosyl- |
| α-Aspartylarginylvalyltyrosylisoleucylhistidylprolylphenylalanylhistidylleucylleucylvalyltyrosylserine |
| Angiotensinogen (1-14)(Porcine) |
| H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-OH |